Ovid Therapeutics Inc.
OVID
$2.42
$0.062.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.17M | -17.41M | -36.33M | -38.18M | -24.97M |
| Total Depreciation and Amortization | 167.00K | 273.00K | 416.00K | 569.00K | 618.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.48M | -17.09M | 3.07M | 2.69M | -25.48M |
| Change in Net Operating Assets | -469.00K | -4.10M | -5.09M | -5.15M | 287.00K |
| Cash from Operations | -41.95M | -38.33M | -37.93M | -40.07M | -49.55M |
| Capital Expenditure | -- | -- | -22.00K | -18.00K | -52.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.01M | -49.85M | 43.52M | 38.76M | 39.56M |
| Cash from Investing | -49.01M | -49.85M | 43.50M | 38.74M | 39.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 161.81M | 75.21M | 28.00K | 51.00K | 407.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.37M | -- | -- | -- | -- |
| Cash from Financing | 164.18M | 75.21M | 28.00K | 51.00K | 407.00K |
| Foreign Exchange rate Adjustments | -289.00K | -167.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | 72.93M | -13.15M | 5.59M | -1.28M | -9.64M |